gamma-aminobutyric acid has been researched along with Catatonia in 17 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
Excerpt | Relevance | Reference |
---|---|---|
" valproate) were studied in rats against perphenazine-induced catatonia." | 7.67 | GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats. ( Garg, SK; Kulkarni, SK; Mathur, VS; Shukla, VK, 1985) |
" The effects of electroconvulsive seizures--the experimental analogue of ECT--should also be tested in gamma-aminobutyric acid-ergic animal models of autistic regression, autism, catatonia, and other neurodevelopmental disorders." | 4.83 | Are autistic and catatonic regression related? A few working hypotheses involving gaba, Purkinje cell survival, neurogenesis, and ECT. ( Dhossche, DM; Rout, U, 2006) |
" valproate) were studied in rats against perphenazine-induced catatonia." | 3.67 | GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats. ( Garg, SK; Kulkarni, SK; Mathur, VS; Shukla, VK, 1985) |
"In DSM-5, catatonia syndrome may be diagnosed as a specifier to major mood disorders, psychotic disorders, general medical conditions, and as catatonia not otherwise specified." | 2.53 | Catatonia. ( Strik, W; Walther, S, 2016) |
"Catatonia is potentially life threatening." | 2.53 | Catatonia. ( Strik, W; Walther, S, 2016) |
"The blueprint for the future study of catatonia in ASDs describes promising clinical and preclinical research avenues." | 2.43 | Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. ( Dhossche, DM; Shah, A; Wing, L, 2006) |
"Modern classificatory schemes define autism and catatonia separately and are not conducive to study areas of overlap." | 2.42 | Autism as early expression of catatonia. ( Dhossche, DM, 2004) |
"The literature on autism and catatonia are reviewed to identify areas of overlap." | 2.42 | Autism as early expression of catatonia. ( Dhossche, DM, 2004) |
"Several areas of overlap between autism and catatonia are found." | 2.42 | Autism as early expression of catatonia. ( Dhossche, DM, 2004) |
"Reports indicate that catatonia often occurs in autism." | 2.42 | Autism as early expression of catatonia. ( Dhossche, DM, 2004) |
"Differences between autism and catatonia of age-of-onset, symptoms, and illness course, do not exclude a common genetic etiology." | 2.42 | Autism as early expression of catatonia. ( Dhossche, DM, 2004) |
"Catatonia is a motor syndrome with abnormalities in neuroendocrine regulation." | 1.31 | Catatonia and ECT: Meduna's biological antagonism hypothesis reconsidered. ( Fink, M, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (29.41) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 3 (17.65) | 2.80 |
Authors | Studies |
---|---|
Hirjak, D | 2 |
Wolf, RC | 2 |
Northoff, G | 2 |
Gouse, BM | 1 |
Spears, WE | 1 |
Nieves Archibald, A | 1 |
Montalvo, C | 1 |
Cooper, JJ | 1 |
Ross, DA | 1 |
Taylor, SF | 1 |
Plevin, D | 1 |
Mohan, T | 1 |
Bastiampillai, T | 1 |
Walther, S | 1 |
Strik, W | 1 |
Fink, M | 1 |
SIEROSLAWSKA, J | 1 |
Dhossche, DM | 4 |
Jibiki, T | 1 |
Song, Y | 1 |
Liu, Y | 1 |
Rout, U | 1 |
Shah, A | 1 |
Wing, L | 1 |
Izumi, K | 1 |
Munekata, E | 1 |
Yamamoto, H | 1 |
Yoshida, M | 1 |
Nakanishi, T | 1 |
Wong, P | 1 |
Barbeau, A | 1 |
Di Chiara, G | 1 |
Morelli, M | 1 |
Porceddu, ML | 1 |
Gessa, GL | 1 |
Lipcsey, A | 1 |
Kardos, J | 1 |
Prinz, G | 1 |
Simonyi, M | 1 |
Shukla, VK | 1 |
Garg, SK | 1 |
Mathur, VS | 1 |
Kulkarni, SK | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders[NCT03980366] | 1 participants (Actual) | Interventional | 2019-03-15 | Terminated (stopped due to We have not obtained additional subjects and chose to terminate/close this study.) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 reviews available for gamma-aminobutyric acid and Catatonia
Article | Year |
---|---|
Catatonia.
Topics: Benzodiazepines; Catatonia; Diagnostic and Statistical Manual of Mental Disorders; Electroconvulsive | 2016 |
Autism as early expression of catatonia.
Topics: Adolescent; Age of Onset; Autistic Disorder; Catatonia; Cerebellum; Child; gamma-Aminobutyric Acid; | 2004 |
[Malignant catatonia and late-onset catatonia].
Topics: Adult; Aged; Catatonia; Cerebral Cortex; Corpus Striatum; Dopamine; Electroconvulsive Therapy; Femal | 2004 |
Is there a connection between autism, Prader-Willi syndrome, catatonia, and GABA?
Topics: Animals; Autistic Disorder; Catatonia; gamma-Aminobutyric Acid; Genetic Markers; Humans; Prader-Will | 2005 |
Are autistic and catatonic regression related? A few working hypotheses involving gaba, Purkinje cell survival, neurogenesis, and ECT.
Topics: Adolescent; Animals; Autistic Disorder; Catatonia; Cell Survival; Child; Electroconvulsive Therapy; | 2006 |
Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders.
Topics: Adult; Animals; Autistic Disorder; Catatonia; Central Nervous System Agents; Child; Electroconvulsiv | 2006 |
11 other studies available for gamma-aminobutyric acid and Catatonia
Article | Year |
---|---|
GABA and Negative Affect-Catatonia as Model of RDoC-Based Investigation in Psychiatry.
Topics: Affect; Catatonia; gamma-Aminobutyric Acid; Humans; Mental Disorders; Psychiatry | 2019 |
Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism.
Topics: Aged; Atrial Fibrillation; Basal Ganglia; Betacoronavirus; C-Reactive Protein; Catatonia; Coronaviru | 2020 |
COVID-19 Catatonia-Would We Even Know?
Topics: Akinetic Mutism; Basal Ganglia; Benzodiazepines; Betacoronavirus; Catatonia; Coronavirus Infections; | 2020 |
GABA
Topics: Antipsychotic Agents; Catatonia; Clozapine; gamma-Aminobutyric Acid; Humans; Receptors, GABA-B | 2021 |
The role of the GABAergic system in catatonia-Insights from clozapine and benzodiazepines.
Topics: Antipsychotic Agents; Benzodiazepines; Catatonia; Clozapine; GABAergic Neurons; gamma-Aminobutyric A | 2018 |
Catatonia and ECT: Meduna's biological antagonism hypothesis reconsidered.
Topics: Amobarbital; Brain; Catatonia; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Hypnotics | 2002 |
PHARMACOLOGIC PROPERTIES OF GAMMA-AMINOBUTYRIC ACID AND ITS DERIVATIVES. II. EFFECT ON THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM.
Topics: Aminobutyrates; Analgesics; Analgesics, Non-Narcotic; Animals; Antipyretics; Behavior, Animal; Birds | 1965 |
Central neuropharmacology of D-Ala2-Met-enkephalinamide and its interactions with taurine in rats.
Topics: Analgesia; Animals; Catatonia; Corpus Striatum; Dopamine; Endorphins; Enkephalin, Methionine; Enkeph | 1981 |
Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
Topics: Animals; Apomorphine; Behavior, Animal; Bicuculline; Catatonia; Corpus Striatum; Drug Interactions; | 1978 |
[Effect of electroconvulsive therapy on the GABA level in the cerebrospinal fluid].
Topics: Adult; Catatonia; Combined Modality Therapy; Electroconvulsive Therapy; Female; gamma-Aminobutyric A | 1986 |
GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats.
Topics: Animals; Bromocriptine; Catatonia; Dopamine; Drug Synergism; GABA Antagonists; gamma-Aminobutyric Ac | 1985 |